UBS Group’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,815
| Closed | -$1.27K | – | 9010 |
|
|
2023
Q1 | $1.27K | Buy |
+1,815
| New | +$1.27K | ﹤0.01% | 7670 |
|
|
2022
Q4 | – | Sell |
-27
| Closed | – | – | 10134 |
|
|
2022
Q3 | $0 | Sell |
27
-17,567
| -100% | – | ﹤0.01% | 10130 |
|
|
2022
Q2 | $73K | Buy |
17,594
+15,127
| +613% | +$62.8K | ﹤0.01% | 4658 |
|
|
2022
Q1 | $9K | Buy |
2,467
+2,442
| +9,768% | +$8.91K | ﹤0.01% | 7549 |
|
|
2021
Q4 | $0 | Buy |
+25
| New | – | ﹤0.01% | 9659 |
|
|
2021
Q3 | – | Sell |
-3,005
| Closed | -$21K | – | 9055 |
|
|
2021
Q2 | $21K | Buy |
3,005
+1,286
| +75% | +$8.99K | ﹤0.01% | 6202 |
|
|
2021
Q1 | $10K | Buy |
1,719
+404
| +31% | +$2.35K | ﹤0.01% | 6924 |
|
|
2020
Q4 | $6K | Buy |
1,315
+367
| +39% | +$1.68K | ﹤0.01% | 6766 |
|
|
2020
Q3 | $4K | Sell |
948
-485
| -34% | -$2.05K | ﹤0.01% | 6580 |
|
|
2020
Q2 | $41K | Buy |
1,433
+1,153
| +412% | +$33K | ﹤0.01% | 5207 |
|
|
2020
Q1 | $6K | Sell |
280
-5,449
| -95% | -$117K | ﹤0.01% | 6333 |
|
|
2019
Q4 | $113K | Buy |
5,729
+5,176
| +936% | +$102K | ﹤0.01% | 4914 |
|
|
2019
Q3 | $8K | Buy |
+553
| New | +$8K | ﹤0.01% | 6333 |
|